How type I interferons may harm the brain after a traumatic head injury
Mechanisms of type I interferon neuropathology following traumatic brain injury
Researchers are looking at whether signals called type I interferons in brain immune cells cause ongoing inflammation and brain damage after traumatic head injury in adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11159621 on NIH RePORTER |
What this research studies
This project focuses on microglia, the brain's immune cells, and how type I interferon signals change after a traumatic brain injury. Scientists will identify which cells make these interferons and how microglia respond over time using laboratory models and tissue analyses. The team will link those immune changes to brain cell loss and to thinking or memory problems that follow injury. Findings are intended to point to specific pathways that could be targeted to reduce harmful inflammation after TBI.
Who could benefit from this research
Good fit: Adults who have experienced a traumatic brain injury and are dealing with ongoing inflammation-related symptoms or cognitive problems would be the most relevant group.
Not a fit: People without a traumatic brain injury or whose symptoms arise from non-inflammatory causes are unlikely to benefit directly from this research.
Why it matters
Potential benefit: If successful, this work could point to new targets for treatments that reduce damaging brain inflammation and protect thinking and memory after TBI.
How similar studies have performed: Prior laboratory work has shown increased interferon-related signals in microglia after TBI, but therapies targeting this pathway in humans remain largely untested.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Newell, Elizabeth — University of Iowa
- Study coordinator: Newell, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.